Download Files:
CYP17-IN-1
SKU
HY-101516-1mg
Category Reference compound
Tags Cancer, Cytochrome P450, Metabolic Enzyme/Protease
$315
Only 1000 item(s) left in stock.
Products Details
Product Description
– CYP17-IN-1 (compound 9c) is a potent and orally active CYP17 inhibitor against rat and human CYP17 with IC50s of 15.8 and 20.1 nM[1].
Web ID
– HY-101516
Shipping
– Room temperature
Applications
– Cancer-programmed cell death
Molecular Formula
– C18H17FN2S
References
– [1]Wang M, et al. Discovery of novel 1,2,3,4-tetrahydrobenzo[4, 5]thieno[2, 3-c]pyridine derivatives as potent and selective CYP17 inhibitors. Eur J Med Chem. 2017 May 26;132:157-172.
CAS Number
– 2093317-51-0
Molecular Weight
– 312.40
SMILES
– CC1=CC=NC=C1CN(CC2)CC3=C2C4=CC(F)=CC=C4S3
Clinical Information
– No Development Reported
Research Area
– Cancer
Solubility
– 10 mM in DMSO
Target
– Cytochrome P450
Isoform
– CYP17
Pathway
– Metabolic Enzyme/Protease
Product type
– Reference compound
Disclaimer: All products are for Research use only unless clearly stated otherwise on the product datasheet. Datasheets provided on the website are drafts for reference purpose only and you are requested to always refer to the hard copy included in the kit for your experimentation. Agdia Products are available for delivery only in Canada.